Emergent BioSolutions to buy Narcan maker Adapt Pharma


REUTERS: Emergent BioSolutions Inc said on Tuesday it would buy privately held Adapt Pharma, beefing up its portfolio with Narcan, the only FDA approved needle-free emergency opioid overdose treatment. Addiction to opioids - mainly prescription painkillers, heroin and fentanyl - has emerged as a serious public health crisis in the United States, especially in rural areas.



from Biotech News